Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) Short Interest Update

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) was the target of a large drop in short interest in July. As of July 31st, there was short interest totaling 2,344 shares, a drop of 46.7% from the July 15th total of 4,398 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average trading volume of 27,653 shares, the days-to-cover ratio is presently 0.1 days.

Hedge Funds Weigh In On Aimei Health Technology

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AFJK. Jane Street Group LLC purchased a new position in Aimei Health Technology during the 4th quarter worth approximately $302,000. Geode Capital Management LLC acquired a new stake in Aimei Health Technology during the 4th quarter valued at $413,000. Quarry LP lifted its holdings in shares of Aimei Health Technology by 6.4% in the third quarter. Quarry LP now owns 167,081 shares of the company’s stock valued at $1,891,000 after purchasing an additional 10,000 shares in the last quarter. Finally, Clear Street Group Inc. lifted its holdings in shares of Aimei Health Technology by 36.5% in the fourth quarter. Clear Street Group Inc. now owns 83,337 shares of the company’s stock valued at $5,334,000 after purchasing an additional 22,294 shares in the last quarter. Institutional investors and hedge funds own 45.58% of the company’s stock.

Aimei Health Technology Trading Up 0.4%

AFJK stock opened at $12.05 on Friday. Aimei Health Technology has a one year low of $6.75 and a one year high of $130.37. The firm has a market capitalization of $38.20 million, a PE ratio of 200.87 and a beta of 0.90. The firm has a 50-day moving average of $20.80 and a two-hundred day moving average of $32.80.

Aimei Health Technology (NASDAQ:AFJK) last announced its earnings results on Thursday, August 13th. The company reported ($0.03) EPS for the quarter.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Aimei Health Technology in a research report on Wednesday, June 24th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has a consensus rating of “Sell”.

About Aimei Health Technology

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.